EFdA-TP tetralithium | MedChemExpress (MCE)
EFdA-TP tetralithium is a potent nucleoside reverse transcriptase (RT) inhibitor. EFdA-TP tetralithium inhibits RT-catalyzed DNA synthesis as an effective immediate or delayed chain terminator (ICT or DCT). EFdA-TP tetralithium inhibits HIV-1 RT with multiple mechanisms[1].
| Trivial name | EFdA-TP tetralithium |
| Catalog Number | HY-138561C |
| Research Area | Infection |
| Purity | ≥98.0% |
| SMILES | O=[P](O[P](O[P](O)(O)=O)(O)=O)(O[Li])OC[C@]1(O[C@@](C[C@@H]1O)([H])N2C3=NC(F)=NC(N)=C3N=C2)C#C.[Li].[Li].[Li] |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/efda-tp-tetralithium.html |